|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Response Genetics has executed an asset purchase agreement with Cancer Genetics as a "stalking horse" bidder to potentially acquire all of the company's assets.
These under-$10 stocks are within range of triggering big breakout trades.